{
  "id": 16909258,
  "title": "GT Metabolic Solutions Announces Series C Growth Investment Led by J.P. Morgan Life Sciences Private Capital",
  "url": "https://urgent.news/2026/10/28/gt-metabolic-solutions-announces-series-c-growth-investment-led-by-j",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-28T13:44:17.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/gt-metabolic-solutions-announces-series-c-growth-investment-led-by-j-p-morgan-life-sciences-private-capital"
  },
  "original_language": "en",
  "account": null,
  "summary": "MINNEAPOLIS — GT Metabolic™ Solutions, Inc. (“the Company” or “GT Metabolic”), a pioneer in the medical device field and the first to receive FDA De Novo grant and 510(k) clearance for use of magnetic technology to create compression anastomoses (connections between two tubular structures in the body, such as intestines), today announced a Series C […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}